TITLE

Controversy about the Cardiovascular Safety of Sibutramine

AUTHOR(S)
Scheen, André J.
PUB. DATE
July 2010
SOURCE
Drug Safety;2010, Vol. 33 Issue 7, p615
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article, the author discusses the cardiovascular safety of sibutamine as the cure of obesity. He agrees that conventional risk-reduction measures such as the use of aspirin and lipid-lowering drugs are proven effective in reducing cardiovascular diseases (CVD) and saving lives of at-risk or obese individuals. He also opines that the research which says that sabutamine may lower the risk of death in overweight is speculative as he sees bias on the conducted research.
ACCESSION #
53384534

 

Related Articles

  • Sibutramine.  // Reactions Weekly;6/17/2006, Issue 1106, p18 

    Presents cases of bruising and ecchymosis after treatment with sibutramine for obesity. Daily dosage of sibutramine received by the patients.

  • SIBUTRAMINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p752 

    The article presents information on sibutramine, an appetite suppressant, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • SIBUTRAMINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p758 

    The article presents information on sibutramine, an appetite suppressant used for the treatment of obesity and maintenance of weight loss. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • SIBUTRAMINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p756 

    The article presents information on sibutramine, an appetite suppressant used for the treatment of obesity and maintenance of weight loss. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • Sibutramine.  // Reactions Weekly;3/14/2009, Issue 1243, p40 

    The article presents a case study of a 27-year-old woman with bipolar I disorders who had been asymptomatic for 18 months while receiving carbamazepine and risperidone. The patient started receiving sibutramine for obesity. She presented with irritability, increased energy and frenzied activity...

  • The unrelenting fall of the pharmacological treatment of obesity. Di Dalmazi, Guido; Vicennati, Valentina; Pasquali, Renato; Pagotto, Uberto // Endocrine (1355008X);Dec2013, Vol. 44 Issue 3, p598 

    Nowadays pharmacological therapy to limit obesity has reached a critical stage: not only have Authorities limited the use of antiobesity drugs due to their proven inefficacy and dangerous side effects, but bariatric surgery has delivered better results. At present, when the number of obese...

  • DRUGS FOR OBESITY. Mead, Mike // Practice Nurse;9/10/2004, Vol. 28 Issue 4, p64 

    Focuses on prescription drugs available to help obese patients to lose weight. Clinical indications of Sibutramine and Orlistat; Contraindications and side effects of the drugs; Importance of monitoring patients who are taking drug therapy.

  • Tolerability and Safety of the New Anti-Obesity Medications. Hainer, Vojtech; Aldhoon-Hainerová, Irena // Drug Safety;Sep2014, Vol. 37 Issue 9, p693 

    Worldwide obesity prevalence has nearly doubled since 1980. Due to numerous co-morbidities, obesity represents a serious health and socioeconomic problem worldwide. Pharmacotherapy should be an integral part of comprehensive obesity management. Drug therapy can assist in weight loss and its...

  • SIZE MATTERS. GREENHALGH, TRISHA // Accountancy;Dec2010, Vol. 146 Issue 1408, p55 

    The author emphasizes the benefit of gastric surgery to severely obese people. She cites some of the diseases related to obesity including diabetes, heart disease and arthritis. She notes the withdrawal of anti-obesity drugs ribonamant and sibutramine from the market due to life-threatening side...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics